ZYME Zymeworks Inc: Multiplikator nilai perusahaan marang pendapatan

Logo perusahaan publik zymeworks.com (ZYME)

Zymeworks Inc. business is completely independent of economic downturns, as confirmed by the current EV/Sales value. The 9092.98 metric determines this level of market valuation. The reliability of sterile antibody supply chains guarantees therapy safety, while the development of a multi-target platform through partnerships minimizes financial risks and competitive pressure during clinical trial stages.

Nilai perusahaan marang pendapatan: Zymeworks Inc (ZYME) kanggo 23.11.2025 - 20.11.2026

zymeworks.com - rincian analitis lan metrik utama (ZYME)

- rega saham lan konsensus proyeksi valuasi:
Analisis wiwitan perusahaan:Zymeworks Inc. ZYME
Sampel barang Zymeworks Inc.

Investors use this criterion to determine the fair value of a business during the initial screening of assets. The metric compares the total enterprise value, including debt and cash, with the volume of generated revenue. This is critical for Zymeworks Inc. (ZYME), as the high cost of antibody development amid competition from CAR-T therapy necessitates strict control over overpayment. By analyzing the EV/Sales multiple history, one can assess the risk of purchasing an overvalued asset during a period of expensive capital.

Analisis pesaing Zymeworks Inc.

IBRX (immunitybio.com) - Rasio nilai perusahaan marang pendapatan|Immunocore Corp (IMCR) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Janux Pharma (JANX)|Nilai perusahaan marang pendapatan RCUS|TNGX - Rasio nilai perusahaan marang dodolan|Nilai perusahaan marang pendapatan IOVA (Iovance)|Koefisien nilai perusahaan marang pendapatan IMTX|Multiplikator EV/Sales XNCR (Xencor)|Nilai bisnis marang pendapatan CMPX|replimune.com - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Lyell Pharma|Innate Pharma S.A. (IPHA) - Rasio nilai perusahaan marang pendapatan|Pyxis Oncology Inc. - Nilai bisnis marang pendapatan|CGEN (Compugen Limited) - Multiplikator EV/Sales|Multiplikator EV/Sales IO Biotech Inc|Rasio nilai perusahaan marang pendapatan Sutro Biopharma (STRO)|INKT: Nilai perusahaan marang volume dodolan|Werewolf Therapeutics, Inc. - Nilai perusahaan marang pendapatan|Immix (IMMX) - Multiplikator nilai perusahaan marang pendapatan|ALX Oncology Holdings Inc. - Multiplikator EV/Sales|CUE - Multiplikator EV/Sales|PDSB: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Sonnet BioTherapeutics Holdings Inc. (SONN)|MAIA (MAIABiotech.com) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan Liminatus Pharma (LIMN)|Multiplikator EV/Sales LVTX|Koefisien nilai perusahaan marang pendapatan NXTC|Leap Therapeutics, Inc. - Nilai perusahaan marang pendapatan|INTS: Rasio nilai perusahaan marang pendapatan|Sensei Biotherapeutics Inc - Multiplikator EV/Sales|TOVX: Rasio nilai perusahaan marang pendapatan|gritstonebio.com (GRTS) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan KA|Rasio nilai perusahaan marang pendapatan NexImmune, Inc.|Rasio nilai perusahaan marang pendapatan TSBX (Turnstone Biologics)|Nilai perusahaan marang pendapatan VCNX (Vaccinex, Inc.)|Koefisien nilai perusahaan marang pendapatan HARP